BluePath Capital Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
BluePath Capital Management's JNJ Position: Q3 2026 in Review
BluePath Capital Management increased its Johnson & Johnson (JNJ) stake by 88% in Q3 2026, buying an estimated $231K and bringing the position to 1,877 shares worth $497K. The position accounts for 0.26% of the portfolio, ranked #104.
BluePath Capital Management first reported a position in JNJ in Q3 2023 and has held it in 5 quarters since. The position peaked at $1.09M in Q4 2023. 1,988 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.
- BluePath Capital Management held 1,877 shares of Johnson & Johnson worth $497K as of Q3 2026.
- BluePath Capital Management bought 877 Johnson & Johnson shares in Q3 2026, an estimated $231K.
- Johnson & Johnson made up 0.26% of BluePath Capital Management's portfolio in Q3 2026, its #104 holding.
- BluePath Capital Management first reported a position in Johnson & Johnson in Q3 2023 and has held it in 5 quarters since.
- BluePath Capital Management's Johnson & Johnson position peaked at $1.09M in Q4 2023.
- 1,988 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.
Based on BluePath Capital Management's 13F filing for Q3 2026, filed 26 Oct 2026.